ADVIK LABORATORIES LTD. Share Price
ADVIK LABORATORIES LTD. Returns Calculator
ADVIK LABORATORIES LTD. Shareholder Returns
ADVIK LABORATORIES LTD. Share Price History
| Name | Mkt Cap Cr | P/E | P/B | ROE | D/E | ROCE | Book Value | Div. Yield | Turnover | EPS(TTM) |
|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 4,80,047.00 | 36.73 | 5.05 | 14.85% | 0.55 | 18.72% | 18.85 | 0.91% | 0.56 | 10.90 |
| Divis Laboratories | 2,08,141.00 | 61.36 | 9.40 | 16.19% | 0.00 | 21.00% | 9.43 | 0.50% | 0.58 | 98.19 |
| Torrent Pharmaceuticals | 1,85,264.00 | 86.65 | 22.03 | 25.49% | 1.69 | 13.85% | 222.76 | 0.69% | 0.41 | 58.70 |
| Cipla | 1,18,992.00 | 35.29 | 3.44 | 11.27% | 0.00 | 14.95% | 423.36 | 0.89% | 0.45 | 43.52 |
| Zydus Lifesciences | 1,11,272.00 | 17.39 | 3.23 | 19.69% | 0.35 | 20.30% | 3.70 | 0.11% | 0.39 | 35.38 |
| Lupin | 1,10,374.00 | 19.83 | 4.71 | 27.01% | 0.03 | 27.44% | 3.51 | 0.78% | 0.61 | 129.18 |
| Mankind Pharma | 1,06,427.00 | 51.48 | 6.53 | 11.74% | 0.34 | 13.13% | 397.02 | 0.04% | 0.44 | 49.37 |
| Laurus Labs | 96,251.20 | 88.28 | 18.16 | 16.77% | 0.40 | 16.14% | 97.20 | 0.11% | 0.67 | 13.72 |
| Dr. Reddy's Laboratories | 95,516.10 | 30.09 | 2.52 | 11.07% | 0.18 | 12.54% | 377.96 | 0.70% | 0.41 | 38.68 |
| Aurobindo Pharma | 91,502.40 | 26.12 | 2.41 | 9.25% | 0.19 | 11.76% | 391.14 | 0.25% | 0.48 | 41.58 |
ADVIK LABORATORIES LTD. Financials
Income Statement · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.03 |
| Other Income | ₹0.05 | ₹0.09 | ₹0.02 | ₹0.26 |
| Total Revenue | ₹0.05 | ₹0.09 | ₹0.02 | ₹0.29 |
| Total Expenses | ₹0.91 | ₹0.95 | ₹1.09 | ₹1.22 |
| Profit Before Tax | -₹0.86 | -₹0.85 | -₹1.07 | -₹0.93 |
| Tax | ₹0.03 | -₹0.02 | -₹0.02 | -₹0.79 |
| Profit After Tax | -₹0.90 | -₹0.83 | -₹1.05 | -₹0.14 |
| EPS - Basic | -₹0.47 | -₹0.43 | -₹0.55 | -₹0.07 |
| EPS - Diluted | -₹0.47 | -₹0.43 | -₹0.55 | -₹0.07 |
Cash Flow · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | -₹0.89 | -₹0.82 | -₹1.04 | -₹0.12 |
| Income before WC changes | -₹0.74 | -₹0.69 | -₹0.90 | -₹0.04 |
| Change in Assets | ₹0.07 | -₹0.02 | -₹0.08 | ₹0.17 |
| Change in Liabilities | ₹0.10 | ₹0.08 | ₹0.12 | -₹4.47 |
| Change in WC | ₹0.17 | ₹0.06 | ₹0.04 | -₹4.30 |
| Cash flow from Operations | -₹0.57 | -₹0.63 | -₹0.87 | -₹4.34 |
| Cash flow from Investing | ₹0.38 | ₹0.12 | -₹0.10 | ₹0.46 |
| Cash flow from Financing | ₹0.18 | ₹0.51 | ₹0.96 | ₹3.88 |
| Total Cash Flow | ₹0.00 | ₹0.00 | -₹0.01 | ₹0.00 |
| Cash (Start of the year) | ₹0.01 | ₹0.01 | ₹0.01 | ₹0.01 |
| Cash (End of the year) | ₹0.00 | ₹0.01 | ₹0.01 | ₹0.01 |
Balance Sheet · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹7.28 | ₹7.81 | ₹8.08 | ₹8.13 |
| Current Assets | ₹2.05 | ₹2.12 | ₹2.10 | ₹2.03 |
| Total Assets | ₹9.33 | ₹9.94 | ₹10.19 | ₹10.16 |
| Current Liabilities | ₹8.07 | ₹7.74 | ₹7.17 | ₹6.08 |
| Net Current Asset | -₹6.02 | -₹5.62 | -₹5.06 | -₹4.05 |
| Non-Current Liabilities | ₹0.18 | ₹0.22 | ₹0.23 | ₹0.25 |
| Equity Capital | ₹1.08 | ₹1.97 | ₹2.79 | ₹3.83 |
| Total Equity & Liabilities | ₹9.33 | ₹9.94 | ₹10.19 | ₹10.16 |
About ADVIK LABORATORIES LTD.
ADVIK LABORATORIES LTD. Financial Highlights
- Revenue: ADVIK LABORATORIES LTD. reported revenue of ₹0.04 crore in FY26 vs ₹0.05 crore in FY25. It showed a decrease of 20.00% on a yearly basis.
- Operating Profit: ADVIK LABORATORIES LTD. reported an operating loss of ₹1.06 crore in FY26 vs ₹0.86 crore in FY25. It showed a decrease of 23.26% on a year-on-year basis.
- Net Profit: ADVIK LABORATORIES LTD. reported a net loss of ₹1.02 crore in FY26 vs ₹0.90 crore in FY25. It showed a decrease of 13.33% on a yearly basis.
ADVIK LABORATORIES LTD. Quarterly Result Highlights
- ADVIK LABORATORIES LTD. reported revenue of ₹0.04 crore in Mar 2026, compared with ₹0.00 crore in Dec 2025.
- ADVIK LABORATORIES LTD. reported an operating loss of ₹0.37 crore in Mar 2026, compared with ₹0.23 crore in Dec 2025, representing a decrease of 60.87% on a quarter-on-quarter (QoQ) basis.
- ADVIK LABORATORIES LTD. reported a loss of ₹0.36 crore in Mar 2026, compared with ₹0.22 crore in Dec 2025, reflecting a decrease of 63.64% on a QoQ basis.
- The earnings per share (EPS) of ADVIK LABORATORIES LTD. stood at ₹0.47 during Mar 2026.
Similar Stocks
FAQs on ADVIK LABORATORIES LTD. Share Price
What is ADVIK LABORATORIES LTD. share price today?
ADVIK LABORATORIES LTD. share price is ₹1.90 as on 20 Jul, 2026, 15:05 IST.
How much is the Mutual Fund shareholding in ADVIK LABORATORIES LTD. shares?
The Mutual Fund Shareholding in ADVIK LABORATORIES LTD. was 0.00% at the end of Jun 2026.
What is the the 52-week high and low of ADVIK LABORATORIES LTD. shares ?
The 52-week high and low of ADVIK LABORATORIES LTD. share is ₹2.47 and ₹1.57 as of 20 Jul, 2026.
What is the market cap of ADVIK LABORATORIES LTD.?
The market capitalisation of ADVIK LABORATORIES LTD. is ₹3.63 Crores as on 20 Jul, 2026.
What are the stock symbols of ADVIK LABORATORIES LTD.?
The stock symbol of ADVIK LABORATORIES LTD. is 531686 on the BSE, and the ISIN is INE537C01019.
What was yesterday's closing price for ADVIK LABORATORIES LTD. shares ?
ADVIK LABORATORIES LTD. shares closed yesterday at ₹1.90 on BSE
How to buy ADVIK LABORATORIES LTD. shares?
To buy ADVIK LABORATORIES LTD. shares, open a demat account with Upstox and complete the KYC process. Once your account is set up, search for the stock and place your order.
Can I buy ADVIK LABORATORIES LTD. shares on Holidays?
No, shares of ADVIK LABORATORIES LTD. or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell ADVIK LABORATORIES LTD. shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.
What is the PE and PB ratio of ADVIK LABORATORIES LTD.?
The PE and PB ratio of ADVIK LABORATORIES LTD. is -3.58 and 50.86 respectively, as on 20 Jul, 2026, 15:05 IST.